Coronary artery calcification (CAC) adds technical challenge and complexity to percutaneous
coronary interventions (PCIs) and is associated with poorer outcomes and major adverse
cardiovascular events.
1
CAC can lead to stent malapposition, asymmetric expansion, and stent underexpansion,
which has been associated with higher rates of device-oriented composite endpoints
such as cardiac death, myocardial infarction related to the target vessel, or target-lesion
revascularization.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients.Cardiovasc Revasc Med. 2008; 9: 2-8
- Safety and effectiveness of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: the DISRUPT CAD II study.Circ Cardiovasc Interv. 2019; 12e008434
- In-stent use of intravascular coronary lithotripsy for restenosis and stent underexpansion: a multicentre experience.Can J Cardiol. 2022; : xxxxxx
- Management of calcific coronary artery lesions: is it time to change our interventional therapeutic approach?.JACC Cardiovasc Interv. 2019; 12: 1465-1478
- A new optical coherence tomography-based calcium scoring system to predict stent underexpansion.EuroIntervention. 2018; 13: e2182-e2189
- Intravascular imaging to guide lithotripsy in concentric and eccentric calcific coronary lesions.Cardiovasc Revasc Med. 2020; 21: 1099-1105
- Optical coherence tomography patterns of stent restenosis.Am Heart J. 2009; 158: 284-293
- Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study.Eur Heart J Cardiovasc Imaging. 2013; 14: 276-284
- Intravascular lithotripsy for the management of undilatable coronary stent: the SMILE registry.Cardiovasc Revasc Med. 2020; 21: 1555-1559
Tovar Forero MN, Sardella G, et al. Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry. [e-pub ahead of print] EuroIntervention 2022. https://doi.org/10.4222/EIJ-D-21-00545.
Article Info
Publication History
Published online: June 14, 2022
Accepted:
June 10,
2022
Received:
June 4,
2022
Publication stage
In Press Journal Pre-ProofFootnotes
See article by Pham et al., pages xxx-xxx, of this issue.
See page 2 for disclosure information.
Identification
Copyright
© 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- In-Stent Use of Intravascular Coronary Lithotripsy for Restenosis and Stent Underexpansion: A Multicentre ExperienceCanadian Journal of Cardiology
- PreviewPercutaneous coronary intervention (PCI) of severe calcified lesions is at high risk of complications (dissection, perforation, stent underexpansion, etc) and suboptimal results have been associated with major cardiac adverse events. Intravascular lithotripsy uses acoustic energy to disrupt the calcified plaque by creating microfractures. The Shockwave C2 (Shockwave Medical Inc, Santa Clara, CA) intravascular lithotripsy system (S-IVL) was approved by the Food and Drug Administration after studies confirming its safety and efficacy.
- Full-Text
- Preview
